tradingkey.logo
搜索
市场行情
自选
新闻
分析
交易工具
选股器
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
搜索

Cumberland Pharmaceuticals Inc

CPIX
添加自选
7.320USD
+0.130+1.81%
收盘 09-18 16:00（美东）
109.83M总市值
亏损市盈率 TTM

Cumberland Pharmaceuticals Inc

7.320
+0.130+1.81%
概览
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

CPIX 财务数据

通过专为投资者打造的一站式数据看板，全面查看 Cumberland Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值
109.83M
股息TTM
0.00
市盈率 TTM
-14.81
每股收益TTM
-0.49
营业收入
44.52M
净利润
-6.48M
净资产收益率
-29.36%
总资产收益率
-10.29%

Cumberland Pharmaceuticals Inc 财报日历

最新发布
8月 7, 2026
每股收益 / 预测值
--/--
营业收入 / 预测值
--/--

财务报表摘要

单季报
单季报+年报
单季报
年报
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-476.53%-0.29
-361.37%-0.22
28.82%-0.10
-18.07%-0.13
35.62%-0.05
160.94%0.08
69.34%-0.14
-49.52%-0.11
-226.90%-0.08
-1131.76%-0.14
-162.12%-0.44
---0.07
--0.06
--0.01
---0.17
----
----
----
----
----
营业收入
-98.46%166.46K
-22.04%9.13M
31.08%13.68M
-8.73%8.29M
10.04%10.84M
37.84%11.71M
11.57%10.44M
-9.92%9.09M
-9.55%9.85M
-7.88%8.50M
2.51%9.35M
-11.63%10.09M
5.73%10.89M
-17.45%9.22M
9.66%9.12M
41.38%11.41M
13.73%10.30M
6.05%11.18M
-18.92%8.32M
-12.74%8.07M
净利润
-477.31%-4.28M
-361.69%-3.29M
25.85%-1.41M
-25.69%-1.94M
31.77%-740.74K
164.59%1.26M
69.75%-1.90M
-47.15%-1.54M
-224.47%-1.09M
-1112.71%-1.95M
-157.89%-6.29M
-156.78%-1.05M
165.30%872.20K
113.87%192.18K
36.57%-2.44M
61.28%-408.64K
-208.71%-1.34M
-930.35%-1.39M
-335.37%-3.85M
-119.06%-1.06M
利润率
-27388.76%-1864.84%
-422.79%-34.40%
42.68%-10.44%
-38.95%-23.50%
39.40%-6.78%
147.60%10.66%
72.95%-18.22%
-60.47%-16.92%
-241.40%-11.20%
-1298.72%-22.39%
-149.92%-67.38%
---10.54%
--7.92%
--1.87%
---26.96%
----
----
----
----
----
毛利率
38.59%100.00%
-17.79%65.14%
13.61%76.21%
3.17%75.90%
0.97%72.15%
15.87%79.25%
-5.34%67.07%
3.85%73.57%
-5.22%71.46%
-6.46%68.39%
37.12%70.86%
--70.84%
--75.40%
--73.11%
--51.68%
----
----
----
----
----
资产负债率
-100.00%0.00%
-1.49%7.38%
-66.25%6.82%
-62.07%7.95%
-62.34%7.72%
-62.02%7.49%
29.28%20.21%
42.37%20.97%
39.31%20.49%
9.85%19.73%
-10.33%15.63%
--14.73%
--14.71%
--17.96%
--17.43%
----
----
----
----
----
利润表
营业收入
-98.46%166.46K
-22.04%9.13M
31.08%13.68M
-8.73%8.29M
10.04%10.84M
37.84%11.71M
11.57%10.44M
-9.92%9.09M
-9.55%9.85M
-7.88%8.50M
2.51%9.35M
-11.63%10.09M
5.73%10.89M
-17.45%9.22M
9.66%9.12M
41.38%11.41M
13.73%10.30M
6.05%11.18M
-18.92%8.32M
-12.74%8.07M
营业利润
-322.82%-3.16M
-342.22%-3.13M
25.56%-1.37M
-15.98%-1.97M
27.20%-747.48K
169.12%1.29M
35.03%-1.84M
9.22%-1.69M
-4591.40%-1.03M
-22.04%-1.87M
20.75%-2.84M
-464.99%-1.87M
101.58%22.86K
-121.34%-1.53M
-9.95%-3.58M
132.71%511.41K
-17.06%-1.45M
-208.51%-692.00K
-110.49%-3.25M
-29.35%-1.56M
净利润
-477.31%-4.28M
-361.69%-3.29M
25.85%-1.41M
-25.69%-1.94M
31.77%-740.74K
164.59%1.26M
69.75%-1.90M
-47.15%-1.54M
-224.47%-1.09M
-1112.71%-1.95M
-157.89%-6.29M
-156.78%-1.05M
165.30%872.20K
113.87%192.18K
36.57%-2.44M
61.28%-408.64K
-208.71%-1.34M
-930.35%-1.39M
-335.37%-3.85M
-119.06%-1.06M
资产负债表
流动资产
7.81%33.64M
2.86%32.79M
1.67%37.06M
-15.03%29.94M
-12.30%31.21M
-11.96%31.88M
2.07%36.45M
-15.64%35.24M
-18.53%35.58M
-17.36%36.21M
-22.14%35.71M
-15.03%41.77M
-0.17%43.67M
-3.38%43.81M
0.40%45.87M
4.12%49.16M
-6.28%43.75M
-8.18%45.34M
-8.57%45.69M
-3.43%47.22M
流动负债总额
46.81%35.19M
35.14%34.49M
16.20%36.74M
-21.80%24.31M
-3.17%23.97M
-3.43%25.52M
13.01%31.62M
13.76%31.09M
-8.17%24.76M
2.79%26.43M
-2.09%27.98M
7.99%27.33M
11.16%26.96M
4.68%25.71M
48.24%28.58M
41.02%25.31M
30.06%24.25M
7.48%24.56M
-24.89%19.28M
-25.03%17.95M
总资产
-7.40%62.88M
1.51%71.00M
1.64%76.82M
-14.14%65.90M
-13.52%67.91M
-14.20%69.94M
-7.57%75.58M
-12.54%76.75M
-12.15%78.52M
-8.90%81.51M
-12.00%81.78M
-3.33%87.75M
-3.40%89.38M
-7.48%89.47M
10.02%92.93M
3.66%90.78M
4.13%92.52M
3.59%96.70M
-12.44%84.46M
-8.79%87.57M
总负债
13.78%45.77M
19.47%49.69M
-1.43%52.28M
-23.30%40.10M
-23.36%40.23M
-23.43%41.60M
0.99%53.04M
0.35%52.28M
-0.10%52.49M
1.68%54.32M
-7.79%52.52M
-0.36%52.10M
-1.45%52.54M
-4.44%53.42M
36.06%56.95M
27.76%52.29M
29.90%53.31M
20.30%55.90M
-15.59%41.86M
-15.03%40.92M
总权益
-38.20%17.11M
-24.83%21.30M
8.86%24.54M
5.44%25.80M
6.33%27.68M
4.23%28.34M
-22.95%22.55M
-31.37%24.47M
-29.33%26.03M
-24.58%27.19M
-18.66%29.26M
-7.37%35.66M
-6.04%36.84M
-11.63%36.05M
-15.56%35.97M
-17.48%38.49M
-18.00%39.20M
-12.98%40.79M
-9.11%42.60M
-2.50%46.65M
现金流量表
经营净额
-560.36%-3.88M
-90.07%387.02K
-99.84%3.02K
-60.64%187.18K
198.61%843.80K
282.46%3.90M
83.12%1.90M
-61.55%475.50K
-116.34%-855.66K
-50.66%-2.14M
-71.41%1.04M
-53.08%1.24M
124.64%5.24M
-842.34%-1.42M
149.80%3.64M
540.11%2.64M
5.91%2.33M
-111.67%-150.50K
392.30%1.46M
-1059.30%-598.79K
投资净额
-723.01%-1.78M
95.02%-61.17K
-11363.83%-3.07M
-464.29%-690.84K
710.77%285.86K
-2010.79%-1.23M
-110.29%-26.81K
299.47%189.64K
51.65%-46.80K
66.65%-58.19K
140.68%260.64K
-113.96%-95.07K
43.91%-96.81K
98.71%-174.45K
-2291.39%-640.77K
728.95%680.80K
-255.76%-172.59K
-4153.90%-13.54M
91.52%-26.80K
83.81%-108.24K
融资净额
-3472.46%-5.39M
86.19%-763.30K
50.54%-681.74K
27.93%-386.88K
51.29%-150.80K
-328.19%-5.53M
7.31%-1.38M
39.18%-536.84K
90.55%-309.57K
236.12%2.42M
46.52%-1.49M
55.67%-882.60K
-171.12%-3.28M
-145.41%-1.78M
-278.19%-2.78M
-619.86%-1.99M
36.52%-1.21M
401.86%3.92M
69.75%-735.30K
141.84%383.02K

营业收入

业务

报告期:
暂无数据

地区

报告期:
暂无数据

常见问题

Cumberland Pharmaceuticals Inc的总收入是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，总收入达到了44.52M（同比变化37.87M）。

Cumberland Pharmaceuticals Inc的流动资产是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，流动资产为37.06M（同比变化1.67）。

Cumberland Pharmaceuticals Inc的总资产是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，Cumberland Pharmaceuticals Inc的总资产为76.82M（同比变化1.64）。

Cumberland Pharmaceuticals Inc的总负债是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，Cumberland Pharmaceuticals Inc的总负债为52.28M（同比变化-1.43）。

Cumberland Pharmaceuticals Inc的总权益是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，Cumberland Pharmaceuticals Inc的总权益为24.54M（同比变化8.86）。

Cumberland Pharmaceuticals Inc的净营业收入是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，Cumberland Pharmaceuticals Inc的净营业收入为-2.79M（同比变化56.59）。

Cumberland Pharmaceuticals Inc的净投资是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，Cumberland Pharmaceuticals Inc的净投资为-4.71M（同比变化-8236.82）。

Cumberland Pharmaceuticals Inc的净融资是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，Cumberland Pharmaceuticals Inc的净融资为-6.75M（同比变化-3525.79）。

Cumberland Pharmaceuticals Inc的每股收益（EPS）是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，每股收益（EPS）为-0.19（同比变化58.57）。

Cumberland Pharmaceuticals Inc的净利润是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，净利润为-2.84M（同比变化56.23）。

Cumberland Pharmaceuticals Inc的净利润率是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，净利润率为-6.43（同比变化62.19）。

Cumberland Pharmaceuticals Inc的毛利率是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，毛利率为75.71（同比变化8.69）。

Cumberland Pharmaceuticals Inc的债务与资产比率是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，债务与资产比率为6.82（同比变化-66.25）。

Cumberland Pharmaceuticals Inc的股东权益回报率（ROE）是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，股东权益回报率（ROE）为-11.88（同比变化51.90）。

Cumberland Pharmaceuticals Inc的资产回报率（ROA）是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，资产回报率（ROA）为-3.76（同比变化54.10）。

Cumberland Pharmaceuticals Inc的营业利润是多少？

根据Cumberland Pharmaceuticals Inc的FY2025财报，营业利润为-2.79M（同比变化56.59）。
tradingkey.logo
风险提示：我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐，且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险，包括可能损失投资的本金，且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告，并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
一般使用条款
隐私政策
Cookie政策